Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
232
Views
3
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

Soluble epoxide hydrolase inhibitors from Docynia indica (Wall.) Decne.

, , , , , ORCID Icon, , ORCID Icon & show all
Pages 5403-5408 | Received 28 Feb 2020, Accepted 10 May 2020, Published online: 08 Jun 2020

References

  • Anand SS, Hawkes C, de Souza RJ, Mente A, Dehghan M, Nugent R, Zulyniak MA, Weis T, Bernstein AM, Krauss RM, et al. 2015. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J Am Coll Cardiol. 66(14):1590–1614.
  • Chi VV. 2012. Dictionary of Vietnamese medicinal plants – New ed. Hanoi: Medicine Publishing House.
  • Cuong NM, Van DT, Son NT, Cuong TD, Khanh PN, Binh NQ, Thanh TTV, Lee JS, Jo AR, Kim YH. 2017. Inhibitory effects of novel diarylheptanoids and other constituents of the rhizomes of Curcuma singularis on the catalytic activity of soluble epoxide hydrolase. Bull Korean Chem Soc. 38(1):112–115.
  • Dung HV, Bach NV, Trung TN, Nhiem NX, Tai BH, Kiem PV, Park S, Lee TH, Kim SY, Kim SH. 2016. Megastigmane glycosides from Docynia indica and their anti‐inflammatory activities. Helv Chim Acta. 99(9):681–686.
  • Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H. 2016. Gaussian 16, revision A.03. Available from: https://gaussian.com/citation_a03/.
  • Hashimoto K. 2019. Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders. Front Pharmacol. 10:36.
  • Huang H, Weng J, Wang M-H. 2016. EETs/sEH in diabetes and obesity-induced cardiovascular diseases. Prostaglandins Other Lipid Mediat. 125:80–89.
  • Jagannathan R, Patel SA, Ali MK, Narayan KV. 2019. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diab Rep. 19(7):44.
  • Jones RD, Liao J, Tong X, Xu D, Sun L, Li H, Yang G-Y. 2019. Epoxy-oxylipins and soluble epoxide hydrolase metabolic pathway as targets for NSAID-induced gastroenteropathy and inflammation-associated carcinogenesis. Front Pharmacol. 10:731.
  • Khanh PN, Duc HV, Huong TT, Son NT, Ha VT, Van DT, Tai BH, Kim JE, Jo AR, Kim YH, et al. 2016. Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from Callistemon citrinus. Fitoterapia. 109:39–44.
  • Kim JH, Cho IS, Ryu J, Lee JS, Kang JS, Kang SY, Kim YH. 2018. In vitro and in silico investigation of anthocyanin derivatives as soluble epoxide hydrolase inhibitors. Int J Biol Macromol. 112:961–967.
  • Liu J, Nakamura S, Zhuang Y, Yoshikawa M, Hussein GME, Matsuo K, Matsuda H. 2013. Medicinal flowers. XXXX. Structures of dihydroisocoumarin glycosides and inhibitory effects on aldose reducatase from the flowers of Hydrangea macrophylla var.thunbergii. Chem Pharm Bull. 61(6):655–661.
  • Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. 2016. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 Diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 133(24):2459–2502.
  • Sun YN, Kim JH, Li W, Jo AR, Yan XT, Yang SY, Kim YH. 2015. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe. Bioorg Med Chem. 23(20):6659–6665.
  • Thao NP, Luyen BTT, Lee JS, Kim JH, Kim YH. 2017. Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim. Bioorg Med Chem Lett. 27(8):1874–1879.
  • Thao NP, Luyen BTT, Kim JH, Jo AR, Yang SY, Dat NT, Van Minh C, Kim YH. 2016. Soluble epoxide hydrolase inhibitory activity by rhizomes of Kaempferia parviflora Wall. ex Baker. Med Chem Res. 25(4):704–711.
  • Vinh LB, Kim JH, Lee JS, Nguyet NTM, Yang SY, Ma JY, Kim YH. 2018. Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from Polygala tenuifolia and in silico approach. Med Chem Res. 27(3):726–734.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.